Taysha Gene Therapies (TSHA) Cash & Current Investments (2020 - 2026)
Taysha Gene Therapies (TSHA) posted Cash & Current Investments of $455.41 million for Q2 2026, up 45.6% from $312.76 million a year earlier and up 64.6% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Taysha Gene Therapies' Cash & Current Investments came in at $319.77 million, up 130.0% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
- In prior years, Taysha Gene Therapies' Cash & Current Investments was $139.04 million in FY2024 (-3.4%), $143.94 million in FY2023 (+63.8%), $87.88 million in FY2022 (-42.1%) and $151.74 million in FY2021 (-39.6%).
- The Q2 2026 figure stands as the highest quarterly Cash & Current Investments in data going back to Q3 2020.
- On a year-over-year basis, Cash & Current Investments has increased in each of the last five quarters, with growth averaging 58.6% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2023, with growth of 344.7%; the weakest was Q3 2022, with a decline of 80.7%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $276.6 million (Q1 2026), $319.77 million (Q4 2025) and $297.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Taysha Gene Therapies | 1.45 Bn | 101.23 Mn | - | 455.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 455.41 Mn |
| Mar 31, 2026 | 276.60 Mn |
| Dec 31, 2025 | 319.77 Mn |
| Sep 30, 2025 | 297.34 Mn |
| Jun 30, 2025 | 312.76 Mn |
| Mar 31, 2025 | 116.59 Mn |
| Dec 31, 2024 | 139.04 Mn |
| Sep 30, 2024 | 157.69 Mn |
| Jun 30, 2024 | 172.74 Mn |
| Mar 31, 2024 | 123.98 Mn |
| Dec 31, 2023 | 143.94 Mn |
| Sep 30, 2023 | 164.28 Mn |
| Jun 30, 2023 | 45.08 Mn |
| Mar 31, 2023 | 63.43 Mn |
| Dec 31, 2022 | 87.88 Mn |
| Sep 30, 2022 | 36.94 Mn |
| Jun 30, 2022 | 68.88 Mn |
| Mar 31, 2022 | 99.27 Mn |
| Dec 31, 2021 | 151.74 Mn |
| Sep 30, 2021 | 191.41 Mn |
API Access
Taysha Gene Therapies Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();